| |
RECENT CASES |
|
| |
|
|
| |
 |
|
| |
|
|
| |
GENERAL INFORMATION |
|
| |
|
|
| |
 |
|
| |
|
|
|
| |
Vincristine |
Oncovin Side Effects: Patient Death from Administration
Errors |
|
| In July 2005, the
Joint Commission International Center for Patient
Safety released an alert entitled “Preventing
Vincristine Administration Errors” detailing
the dangers of improper administration of the
cancer drug Vincristine, sold under the brand
name Oncovin or Vincasar PFS. |
| The drug slows or
stops the growth of cancer cells in the body,
and is used to treat leukemia and various other
forms of cancer. The
drug is only meant to be administered intravenously
(injected directly into a vein), and can pose
serious danger when inadvertently given intrathecally
(injected into the fluid surrounding the spinal
cord).
|
|
|
|
|
| Vincristine
administration errors, principally
injection mistakes, have killed
numerous innocent victims.
If you or a family member have
been harmed by a flawed vincristine
injection, click
here to contact us or call
1-800-541-7358 and ask to speak
to attorney Fabrice N. Vincent. |
|
|
|
| When Vincristine is administered
intrathecally, it can lead to serious injuries,
permanent paralysis, or death. There have been a number of cases reported
to various health agencies of injury or death from
improper administration of the drug. |
| Despite
repeated warnings over the years and extensive
labeling requirements and standards, tragic
errors related to administration errors of
Vincristine continue to occur. |
| The United States
Pharmacopeia (USP) requires that a label stating “FATAL
IF GIVEN INTRATHECALLY. FOR
IV USE ONLY. DO
NOT REMOVE COVERING UNTIL MOMENT OF INJECTION” be
applied to each syringe of Vincristine by the
person doing the dispensing, as well as to
an overwrap in which each syringe is to be
placed. Despite
the labeling requirements and dispensing standards,
some health care workers may not be aware of
these requirements.
|
| Furthermore, even
in the event that a syringe is properly labeled
and packaged, if it is prematurely removed
from the overwrap, a physician -- whose attention
is focused on performing a procedure -- may
overlook the labeling and inadvertently use
the Vinchristine syringe instead of a medication
intended for intrathecal injection. |
|
|
|
|
| Lieff
Cabraser has participated in
over twenty $100 million-plus
settlements & verdicts
since 1992. To read a summary, click
here. |
|
|
|
|
|
|
Our lawyers
have years of experience successfully representing clients
in personal injury cases. |
|
|
There
is no charge or obligation for our review of your case. |
|
|
In death
and serious injury cases, we are pleased to visit you where
you live, at no cost, to discuss your legal rights and answer
your questions. |
|
|
We have
retained product safety and medical experts nationwide to
assist our clients with their claims. |
|
|
|
| Various other reported
reasons for error also exist. Therefore, the intrathecal injection of
Vincristine can be the end-result of either a single
error or a series of system errors, all of which
can be prevented through implementation and enforcement
of appropriate safety protocols.
|
| In its alert, the Joint
Commission International Center for Patient Safety
provides the following recommendations for preparing,
dispensing, and administering intravenous Vincristine: |
- Dilute intravenous Vincristine in a volume—ideally
for IV infusion in a minibag—that precludes
administration via the intrathecal route.
- If Vincristine is to be administered via
syringe, clearly label each Vincristine syringe: "FATAL
IF GIVEN INTRATHECALLY. FOR IV USE ONLY. DO
NOT REMOVE COVERING UNTIL MOMENT OF INJECTION." Each
syringe also must be placed in an overwrap
carrying the same label warning.
- Do not dispense intravenous Vincristine (or
any IV medication) in a manner that would permit
it to be administered at a time and location
where intrathecal medications are administered.
If a dedicated location for intrathecal administration
is not possible, the pharmacy should not dispense
IV Vincristine to a location where intrathecal
medications are administered until it receives
confirmation that intrathecal drug administration
is not imminent or has been completed.
- Conduct a "time out" with at least two qualified
health care professionals to independently
verify and document the drug, dose and route
at the time of pharmacy preparation of intravenous
Vincristine and before each administration
of intravenous Vincristine.
|
| If you or a loved one
has suffered from an error in the administration
of Vincristine or Oncovin, please click here to contact Lieff Cabraser or contact Lieff
Cabraser lawyer Fabrice N. Vincent toll-free at
1-800-541-7358.
|
| There is no charge for
your email message or telephone call. We will review
your claim for free and without any obligation
on your part. Lieff Cabraser has successfully
represented families of patients who died from
Vincristine or Oncovin side effects. |
| Founded in 1972, Lieff Cabraser Heimann & Bernstein,
LLP is an over fifty attorney
law firm with offices in San Francisco, New York and Nashville. For the last seven years,
the National Law Journal has recognized Lieff Cabraser
as one of the top 20 plaintiff law firms in America. |
| For our personal injury cases, we bring a team of experienced
lawyers. Each client is assigned an individual lawyer. In addition, we have
on staff multiple nurses, legal assistants, scientific analysts and case
clerks to assist the attorneys. To learn more about our firm, click
here. |
|
|
| Trademark
Notice: Personal Injury Lawyer America is an electronic newsletter
from Lieff Cabraser Heimann & Bernstein, LLP. Lieff Cabraser
represents clients in a wide range of cases, including personal
injury and wrongful
death lawsuits. Our personal injury attorneys
| lawyers are committed to providing the very best representation
and support possible for our clients. |
Lieff Cabraser
is not affiliated in any way with any trademark owner. The use of
any trademarks on this site is for product identification and information
purposes only.
About Lieff Cabraser: We have
offices in San Francisco, New York and Nashville. Our lawyers have
represented clients in personal injury, wrongful death and
rollover crashes and product defect lawsuits across America.
Disclaimer: The hiring of legal
professionals is an important decision that should not be based on
advertising alone. Please read our disclaimer. |
| Copyright © 2010 Lieff Cabraser Heimann & Bernstein, LLP |
|
|
|